\
&
Contact us
Digital, Industry & Space Joint Research Center SPACE
The Belgium, Netherlands and Germany are in competition to build the Einstein Telescope in the Meuse-Rhine region. High-tech companies are invited to join the development of this project. For more information and to declare interest to be part of the ecosystem around the Einstein Telescope, please access the Einstein Telescope for business... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.